| Previous Close | 192.38 |
| Open | 193.00 |
| Bid | 189.51 x 2200 |
| Ask | 190.45 x 1000 |
| Day's Range | 187.88 - 193.51 |
| 52 Week Range | 135.52 - 308.00 |
| Volume | 1,574,076 |
| Avg. Volume | 3,793,738 |
| Market Cap | 29.33B |
| Beta (5Y Monthly) | 0.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.36 |
| Earnings Date | Apr 28, 2021 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 256.79 |
Cathie Wood has become one of the investing world's most popular figures over the last year -- and for good reason. The founder and CEO of ARK Invest has helped put together a collection of actively managed exchange-traded funds (ETFs) that have absolutely crushed the market over the stretch, and she's shown a penchant for identifying innovative, tech-focused companies that have gone on to record huge gains. With ARK funds putting up such incredible performance, we asked three Motley Fool contributors to dive into the list of individual stocks that Wood's company is backing and pick out some favorites.
When Cathie Wood talks, investors listen. The founder of Ark Invest has successfully predicted stock market stars -- one of her top holdings is Tesla. Now, here's some great news for all of us who want to follow this investment superstar's lead: Right now, you can buy three of the biggest holdings in her Ark Genomic Revolution ETF at a bargain.
The administration's focus on the Affordable Care Act, access to healthcare, and research may accelerate growth for these three stocks.